J9345 Injection, retifanlimab-dlwr, 1 milligrams
J-Codes
Also known as: retifanlimab, Opcelifan
Injection of retifanlimab-dlwr, 1 milligram. A programmed cell death 1 (PD-1) monoclonal antibody checkpoint inhibitor.
Clinical Context
Used for cutaneous squamous cell carcinoma and other PD-1-responsive malignancies. Checkpoint inhibitor promoting T-cell anti-tumor immunity.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.